1) Strategy & Leadership - Ingersoll Rand (IR) reported a solid start to Q1 2026, with adjusted EPS growing high single digits and revenue aligning with expectations. - The company emphasizes a disciplined approach to M&A, with a robust acquisition pipeline focused on differentiated technology and services. - The recent signing of Fox s.r.l. is expected to enhance IR's pump technology, showcasing the company's commitment to operational execution and capital allocation.

2) Financial & Segment Results - Q1 orders increased by 5% YoY, with a book-to-bill ratio of 1.07x. However, a $40 million order delay due to Middle East conflicts impacted organic growth, which was flat YoY when excluding this delay. - Total revenue grew 8% YoY, with adjusted EBITDA at $469 million and a margin of 25.4%. Corporate costs were $38 million, and adjusted EPS was $0.77, up 7% YoY. - Free cash flow for Q1 was $163 million, with total liquidity near $4 billion and leverage below 2x, providing flexibility for capital deployment.

3) Problems / Headwinds - The company faced delays in long-cycle projects, particularly in the Middle East, which are expected to recover throughout 2026. Approximately one-third of delayed orders were recovered in April. - Margin pressure was noted due to organic volume declines, tariffs, and strategic investments for growth. The adjusted EBITDA margin is expected to remain under pressure in Q2 but improve in the second half of the year.

4) Operational or Product Plans - The ITS segment saw orders up 5%, with a book-to-bill of 1.08x, although organic orders were down 3%. The PST segment reported a 6% increase in orders, with Life Sciences showing double-digit growth. - IR continues to focus on innovation, highlighted by a significant win in carbon capture technology, and is optimistic about the Life Sciences business, which is expected to maintain robust growth.

5) Guidance & Outlook / Investor Angle - For full-year 2026, IR expects total revenue growth between 2.5% and 4.5%, with adjusted EBITDA projected between $2.13 billion and $2.19 billion. Adjusted EPS is expected to range from $3.45 to $3.57, reflecting approximately 5% growth at the midpoint. - The company remains confident in its ability to navigate the complex global environment and deliver long-term shareholder value through disciplined execution and capital allocation.

Bottom line: Ingersoll Rand's Q1 2026 results reflect a solid start with strong operational execution and a robust acquisition pipeline, despite facing headwinds from order delays and margin pressures. The company is well-positioned for recovery and growth, making it an attractive investment for shareholders.